Bleichroeder LP 13D and 13G filings for Cue Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-21 7:14 pm Unchanged | 2025-03-19 | 13G | Cue Biopharma, Inc. CUE | Bleichroeder LP | 6,127,662 9.990% | 0 (Unchanged) | Filing |
| 2024-10-07 5:07 pm Purchase | 2024-09-30 | 13G | Cue Biopharma, Inc. CUE | Bleichroeder LP | 6,127,662 9.990% | 3,372,634 (+122.42%) | Filing |
| 2024-03-11 6:40 pm Purchase | 2024-02-27 | 13G | Cue Biopharma, Inc. CUE | Bleichroeder LP | 2,755,028 6.110% | 2,755,028 (New Position) | Filing |